Latest filing published 18 Feb 2026 for ABIVAX, €150k. Read the official filing
June Kim (board member) discloses dealings in Abivax to AMF. In total, 2 filings cover trades dated from 26 April 2024 to 13 February 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 18 February 2026, the filings show a transaction worth €150k in Abivax. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.